Loading...
Loading...
Clinical decision support tool. Does not replace professional veterinary judgment. Always verify recommendations with current references.
| Condition | Prevalence | Onset | Severity | Screening |
|---|---|---|---|---|
| Dilated Cardiomyopathy (DCM) | 25-30% | 4-8 years | LIFE THREATENING | Echocardiogram annually from age 2 |
| Osteosarcoma | Highest breed incidence | 5-10 years | LIFE THREATENING | — |
| Gastric Dilatation-Volvulus (GDV) | Elevated | Any age | LIFE THREATENING | — |
Low body fat → prolonged recovery from lipid-soluble agents (thiopental, propofol). Reduce induction doses 25-50%. Use lean-body-mass dosing. CYP2B11 deficiency in Greyhounds = slow barbiturate/propofol metabolism. Prefer alfaxalone for induction. Extended post-anesthetic monitoring required.